Lead Claims Processor

Prime's creative and brand work receives industry recognition. Prime Therapeutics creative services team wins 12 platinum and eight gold marcom awards. After Prime Therapeutics (Prime) announced its bold new brand and purpose to reimagine pharmacy solutions last year, Prime continues to show up as a different kind of pharmacy benefit management (PBM), including through its award-winning visual identity and messaging. The brand identity work recently received sweeping recognition from the 2025 Marcom Awards, which recognizes excellence in marketing and communications, as well as from the 2025 Graphic Design USA (GDUSA) American Inhouse Design Awards, which showcases outstanding design work. "These awards speak to the importance of how Prime shows up in the marketplace," said David Mitchell, vice president, marketing. "It's critical that our marketing and creative work reflects our brand's purpose, vision and culture." "These recognitions are truly a collaborative win across our marketing department and throughout Prime as an enterprise," he added. "I am so grateful for my team's work bringing Prime's distinctive identity to life." Prime recently received 12 platinum and eight gold marcom Awards, which recognized Prime's industry-leading creative work. GDUSA American Inhouse Design Awards. Earlier this year, the Creative team also earned 10 Graphic Design USA (GDUSA) American Inhouse Design Awards. These awards recognized the compelling new brand look and feel that represented Prime's transformation in the marketplace. This year marks Prime's 12th year of recognition, with nearly 100 GDUSA awards won to date. * 2024 President's Awards * Pharmacy Summit Branding * Reimagining The Board of Directors Suite * The Prime Rebrand * Its Solutions: Save, Simplify, Support * Brand Anthem: Transformation * Specialty Summit Environmental Graphics * Pharmacy Friends Social Media * Reimagining Its Website * Prime Cares & Prime Foundation Branding

Prime Therapeutics expands Sempre Health partnership to rein in drug costs. The initiative has generated $4.7 million in member savings since its inception. Pharmacy benefit manager Prime Therapeutics is expanding its partnership with Sempre Health, a company that applies discounts at the pharmacy counter for people taking single-source drugs for chronic conditions. The initiative, focusing on expanding access to behavior-based medications, is meant to give clients new ways to help their commercial members save money and stay on therapy. Recent data from Prime's client, Blue Cross and Blue Shield of North Carolina, shows positive results from the model. Since launching in 2022, the program has enrolled more than 19,500 patients, supported over 70,000 prescription fills and generated $4.7 million in member savings. The initiative also achieved a Net Promoter Score of 98 and increased medication adherence by 15 percentage points, according to Prime. "The outcomes with Blue Cross NC and Sempre show exactly why we invest in initiatives like this: to make healthcare more affordable, improve adherence and support healthier lives," said Christopher Saliba, vice president of Enterprise Solutions at Prime. The companies will be expanding the model nationwide. Prime shared data from KFF showing that nearly 30% of Americans skip prescriptions due to cost, driving an estimated $290 billion in avoidable medical expenses each year. Sempre's behavior-based pricing model rewards healthy behaviors like timely refills and sustained adherence through partnerships with health plans, life science companies and pharmacy benefit managers (PBMs), including Prime. "Too many people are forced to choose between paying their bills and filling their prescription," said Anurati Mathur, CEO of Sempre Health. "Our work with Prime Therapeutics means that millions of people can stay on their life-saving medications without financial strain. We're thrilled to scale this impact nationwide." Prime Therapeutics is one of the largest PBMs in the country, with about a 10.3% market share, according to American Hospital Association data published last fall. Along with CVS Health (with a 21.3% market share), OptumRx (20.8%) and Express Scripts (17.1%), the country's four largest PBMs control roughly 70% of the national market. Michigan Attorney General Dana Nessel filed a lawsuit against Express Scripts and Prime Therapeutics in May, claiming the two pharmacy benefit managers allegedly engaged in anticompetitive conduct that harmed independent pharmacies in the state. According to the lawsuit, the PBMs allegedly formed an unlawful agreement that suppressed reimbursement rates to independent pharmacies, enabling them to pull in profits at the expense of independent pharmacies. Jeff Lagasse is editor of Healthcare Finance News. Healthcare Finance News is a HIMSS Media publication.